Evaluation of preventive effects of pentoxifylline on contrast-induced nephropathy in diabetic patients undergoing angioplasty: A randomized controlled trial

Evaluation of preventive effects of pentoxifylline on contrast-induced nephropathy in diabetic patients undergoing angioplasty: A randomized controlled trial


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: طاهر انتظاری ملکی , ناصر اصلان آبادی , فریبا پورکریم

عنوان کنگره / همایش: بیست و یکمین سمینار دانشجویان داروسازی , Iran (Islamic Republic) , اهواز , 2018

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله فریبا پورکریم
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات قلب وعروق
کد مقاله 69009
عنوان فارسی مقاله Evaluation of preventive effects of pentoxifylline on contrast-induced nephropathy in diabetic patients undergoing angioplasty: A randomized controlled trial
عنوان لاتین مقاله Evaluation of preventive effects of pentoxifylline on contrast-induced nephropathy in diabetic patients undergoing angioplasty: A randomized controlled trial
نوع ارائه پوستر
عنوان کنگره / همایش بیست و یکمین سمینار دانشجویان داروسازی
نوع کنگره / همایش ملی
کشور محل برگزاری کنگره/ همایش Iran (Islamic Republic)
شهر محل برگزاری کنگره/ همایش اهواز
سال انتشار/ ارائه شمسی 1396
سال انتشار/ارائه میلادی 2018
تاریخ شمسی شروع و خاتمه کنگره/همایش 1396/12/15 الی 1396/12/18
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی Cardiovascular Research Centre, Tabriz University of Medical Sciences, Tabriz, Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
طاهر انتظاری ملکیدوم
ناصر اصلان آبادیسوم
فریبا پورکریماول

اطلاعات تفضیلی
hide/show

عنوان متن
کلمات کلیدیAngioplasty, Contrast-induced nephropathy (CIN), Pentoxifylline, Diabetes
خلاصه مقالهIntroduction and background: Contrast-induced nephropathy (CIN) is one of the complications of contrast media usage for diagnosis or treatment of heart diseases. We aimed to evaluate the efficacy of pentoxifylline (PTX) for the prevention of CIN in patients with diabetes undergoing angioplasty. In this study, cystatin C has been used as a novel marker of renal function. Methods: The present study was a randomized clinical trial study. This investigation focuses on 90 diabetic patients over 18 years old who had been referred to Shahid Maddani Hospital for angioplasty. Patients were assigned randomly into two groups. For cases group besides routine procedures, 400 mg PTX three times per day from 24 hours before to 24 hours after angioplasty was administered orally. The control group only received routine procedures. In order to evaluate renal function, cystatin C levels in patients 24 h after angioplasty measured and compared. Results: The initial value of cystatin C were measured (Case group=0.39±1.31 and control group=0.42±1.24), after angioplasty the value for both groups increased (Case group=0.61±1.33 and control group=0.47±1.31). This increase was not significant in any of the groups (respectively, P=0.673 and P=0.244). Comparison of cystatin C value after angioplasty in both groups did not show a statistically significant difference (P=0.912). Discussion and Conclusion: The results of this investigation have indicated that the use of PTX had no significant effect on prevention of CIN in diabetic patients after angioplasty.

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Evaluation of preventive effects of pantoxifylline.pdf1398/06/28519615دانلود
certificate.Evaluation of preventive effects of pantoxifylline.pdf1398/06/28533740دانلود